These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 12544532
41. Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab. Robertson LP, Hickling P. Rheumatology (Oxford); 2001 Apr; 40(4):473-4. PubMed ID: 11312390 [No Abstract] [Full Text] [Related]
42. [Behçet's disease and the possibilities of modern tumour necrosis factor inhibiting medication]. van Laar JA, Jamnitski A, Baarsma GS, van Daele PL, van Hagen PM. Ned Tijdschr Geneeskd; 2006 Apr 01; 150(13):705-9. PubMed ID: 16623340 [Abstract] [Full Text] [Related]
43. Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy. Goossens PH, Verburg RJ, Breedveld FC. Ann Rheum Dis; 2001 Jun 01; 60(6):637. PubMed ID: 11350856 [No Abstract] [Full Text] [Related]
44. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects. Tognon S, Graziani G, Marcolongo R. Ann N Y Acad Sci; 2007 Sep 01; 1110():474-84. PubMed ID: 17911463 [Abstract] [Full Text] [Related]
45. Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease. Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Suzuki K, Tanaka Y. Rheumatology (Oxford); 2009 Aug 01; 48(8):1012-3. PubMed ID: 19465589 [No Abstract] [Full Text] [Related]
46. Antitumor necrosis factor monoclonal antibody therapy in a woman with severe Adamantiades-Behçet's disease. Behrens F, Zollner T, Moeller B, Kaltwasser JP, Kaufmann R, Ochsendorf FR. Adv Exp Med Biol; 2003 Aug 01; 528():561-2. PubMed ID: 12918764 [No Abstract] [Full Text] [Related]
48. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature. Hatemi I, Hatemi G, Pamuk ON, Erzin Y, Celik AF. Clin Exp Rheumatol; 2015 Aug 01; 33(6 Suppl 94):S129-37. PubMed ID: 26486925 [Abstract] [Full Text] [Related]
49. Successful treatment of genital ulcers with infliximab in Behcet's disease. Haugeberg G, Velken M, Johnsen V. Ann Rheum Dis; 2004 Jun 01; 63(6):744-5. PubMed ID: 15140785 [No Abstract] [Full Text] [Related]
50. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease. Belzunegui J, López L, Paniagua I, Intxausti JJ, Maíz O. Clin Exp Rheumatol; 2008 Jun 01; 26(4 Suppl 50):S133-4. PubMed ID: 19026138 [No Abstract] [Full Text] [Related]
54. New approaches in the treatment of Adamantiades-Behçet's disease. Pipitone N, Olivieri I, Cantini F, Triolo G, Salvarani C. Curr Opin Rheumatol; 2006 Jan 01; 18(1):3-9. PubMed ID: 16344613 [Abstract] [Full Text] [Related]
56. Treatment with infliximab for a child with Behçet's disease. Saulsbury FT, Mann JA. Arthritis Rheum; 2003 Aug 15; 49(4):599-600. PubMed ID: 12910569 [No Abstract] [Full Text] [Related]
58. A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade. Alty JE, Monaghan TM, Bamford JM. Clin Neurol Neurosurg; 2007 Apr 15; 109(3):279-81. PubMed ID: 17174468 [Abstract] [Full Text] [Related]